Eruptive keratoacanthomas(KAs) of the lower extremity is considered a severe disease because there is a rapid onset of eruptions with a high recurrence rate. Currently, there are only 40 cases reported.1 The condition most commonly affects Fitzpatrick skin type I and II adults in the fifth to seventh decades of life.2 Treatment and management can be challenging due to their chronic and recurring nature and the patient’s ability to tolerate treatment. However, treatment with the oral retinoid acitretin has been successful in the management of the condition.
Duffy P. Evaluation and Management of Eruptive Keratoacanthomas of the Lower Extremity. Lynchburg Journal of Medical Science. 2022; 4(4).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.